Search Results - "Shahrokh, Shabnam"

Refine Results
  1. 1

    Prevalence of the pathobiont adherent‐invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta‐analysis by Nadalian, Banafsheh, Yadegar, Abbas, Houri, Hamidreza, Olfatifar, Meysam, Shahrokh, Shabnam, Asadzadeh Aghdaei, Hamid, Suzuki, Hidekazu, Zali, Mohammad Reza

    Published in Journal of gastroenterology and hepatology (01-04-2021)
    “…Background and Aim Escherichia coli pathobionts and particularly the adherent‐invasive E. coli (AIEC) may play a putative role in initiating and maintaining…”
    Get full text
    Journal Article
  2. 2

    Effectiveness of a novel diet in attenuation of clinical activity of disease in patients with ulcerative colitis: a randomized, clinical trial by Narimani, Behnaz, Sadeghi, Amir, Daryani, Nasser Ebrahimi, Shahrokh, Shabnam, Nilghaz, Maryam, Ghods, Maryam, Shafiee, Mahshad, Shahparvari, Mohammad Reza, Hekmatdoost, Azita

    Published in Scientific reports (14-06-2024)
    “…Dietary intake plays a pivotal role in ulcerative colitis (UC) initiation and prognosis. The aim of this study was to investigate the effect of a combined…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results by Hossein-khannazer, Nikoo, Torabi, Shukoofeh, Hosseinzadeh, Ramin, Shahrokh, Shabnam, Asadzadeh Aghdaei, Hamid, Memarnejadian, Arash, Kadri, Nadir, Vosough, Massoud

    “…Inflammatory bowel diseases (IBDs) are chronic and relapsing disorders that affect the quality of life in many individuals around the world. Over the past few…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Evaluation of the mTORC activity in the presence of Toxoplasma gondii and azathioprine in human monocyte cell line by Nemati, Sara, Mohammad Rahimi, Hanieh, Meyfour, Anna, Pazoki, Hossein, Asadzadeh Aghdaei, Hamid, Shahrokh, Shabnam, Mirjalali, Hamed

    Published in BMC microbiology (21-03-2023)
    “…Autophagy is an important part of pathogenesis of IBD. Thiopurines such as azathioprine (AZA) are approved drugs for clinical practices in IBD patients…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Detection and quantification of Epstein–Barr virus, cytomegalovirus, and human herpesvirus‐6 in stomach frozen tissue of chronic gastritis and gastric cancer patients by Sarshari, Behrang, Mohebbi, Seyed Reza, Ravanshad, Mehrdad, Shahrokh, Shabnam, Aghdaei, Hamid Asadzadeh, Zali, Mohammad Reza

    Published in Microbiology and immunology (01-08-2022)
    “…Human herpes viruses (HHVs) are among the most common infectious agents detected in the gastrointestinal tract that might be involved in oncogenesis and other…”
    Get full text
    Journal Article
  10. 10

    Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice by Hatamnejad, Mohammad Reza, Baradaran Ghavami, Shaghayegh, Shirvani, Marzieh, Asghari Ahmadabad, Mona, Shahrokh, Shabnam, Farmani, Maryam, Sherkat, Ghazal, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza

    Published in Frontiers in immunology (06-10-2022)
    “…IBD, a chronic inflammatory disease, has been manifested as a growing health problem. No Crohn's and Colitis councils have officially ratified anti-depressants…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Toxoplasma gondii profilin and tachyzoites RH strain may manipulate autophagy via downregulating Atg5 and Atg12 and upregulating Atg7 by Nemati, Sara, Pazoki, Hossein, Mohammad Rahimi, Hanieh, Asadzadeh Aghdaei, Hamid, Shahrokh, Shabnam, Baghaei, Kaveh, Mirjalali, Hamed, Zali, Mohammad Reza

    Published in Molecular biology reports (01-10-2021)
    “…Background Autophagy process is an important defense mechanism against intracellular infection. This process plays a critical role in limiting the development…”
    Get full text
    Journal Article
  13. 13

    A prediction of the CRNDE role by modulating NF-κB pathway in inflammatory bowel disease (IBD) by Kazemifard, Nesa, Farmani, Maryam, Baradaran Ghavami, Shaghayegh, Kazemi, Mohammad, Shahrokh, Shabnam, Asadzadeh Aghdaei, Hamid, Zali, Mohammadreza

    Published in Biochemistry and biophysics reports (01-07-2024)
    “…Long non-coding RNAs (lncRNAs) regulate multiple pathways and cellular mechanisms. Recent research has emphasized their involvement in the pathogenesis of…”
    Get full text
    Journal Article
  14. 14

    Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study by Derakhshan Nazari, Mohammad Hossein, Shahrokh, Shabnam, Ghanbari-Maman, Leila, Maleknia, Samaneh, Ghorbaninejad, Mahsa, Meyfour, Anna

    Published in Heliyon (01-11-2023)
    “…Nowadays, anti-TNF therapy remarkably improves the medical management of ulcerative colitis (UC), but approximately 40 % of patients do not respond to this…”
    Get full text
    Journal Article
  15. 15

    The Sera miRNA Pattern in Patients Inflammatory Bowel Disease by Ghorbani, Mohammad Hossein, Chaleshi, Vahid, Amiri, Nazanin, Nasserinejad, Maryam, Ghavami, Shaghayegh Baradaran, Shahrokh, Shabnam, Vosough, Massoud Z, Aghdaei, Hamid Asadzadeh, Zali, Mohammad Reza

    Published in Acta medica Iranica (08-06-2024)
    “…Inflammatory bowel disease comprising Crohn's disease and ulcerative colitis presents with periods of flares and remission. Many reports have identified…”
    Get full text
    Journal Article
  16. 16

    Phylogrouping and characterization of Escherichia coli isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran by Nadalian, Banafsheh, Nadalian, Bahareh, Houri, Hamidreza, Shahrokh, Shabnam, Abdehagh, Mohammad, Yadegar, Abbas, Ebrahimipour, Gholamhossein

    Published in Frontiers in medicine (29-08-2022)
    “…Background Although the etiopathogenesis of inflammatory bowel disease (IBD) is still poorly understood, Escherichia coli has been described as a potential…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients by Aghdaei, Hamid Asadzadeh, Kadijani, Azade Amini, Sorrentino, Dario, Mirzaei, Alireza, Shahrokh, Shabnam, Balaii, Hedieh, Geraci, Marco, Zali, Mohammad Reza

    Published in United European gastroenterology journal (01-08-2018)
    “…Background Predicting the response of inflammatory bowel disease (IBD) patients to infliximab (IFX) is an unmet clinical need. The expression and density of…”
    Get full text
    Journal Article
  20. 20